!!Major publications  Prof. Moshe Yaniv out of 320 publications

\\
1.	M. YANIV, A. FAVRE and B.G. BARRELL. Evidence for interaction between two non-adjacent nucleotide residues in tRNAval from E. coli. Nature, 1969, 223, 1331-1333.
\\ \\
2.	J. NINIO, A. FAVRE and M. YANIV. Molecular model for transfer RNA. Nature, 1969, 223, 1333-1335.
\\ \\
3.	M. YANIV and B.G. BARRELL. Sequence relationship of three valine acceptors tRNAs from E.coli. Nature New Biol., 1971, 233, 113-114.
\\ \\
4.	W.R. FOLK and M. YANIV. Coding properties and nucleotide sequences of E.coli glutamine tRNA's. Nature New. Biol., 1972, 237, 165-166.
\\ \\
5.	M. YANIV, W.R. FOLK, P. BERG and L. SOLL. A single mutational modification of a tryptophan specific tRNA permits aminoacylation by glutamine and translation of UAG. J. Mol. Biol., 1974, 86, 245-260.
\\ \\
6.	C. CREMISI, P.F. PIGNATTI, O. CROISSANT and M. YANIV. Chromatin like structures in Py virus and SV40 lytic cycle. J. Virol., 1976, 17, 204-211.
\\ \\
7.	C. CREMISI, A. CHESTIER and M. YANIV. Preferential association of newly synthesized histones with replicating SV40 DNA. Cell, 1977, 12, 947-951.
\\ \\
8.	S. SARAGOSTI, G. MOYNE and M. YANIV. Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA. Cell, 1980, 20, 35-73.
\\ \\
9.	M. KATINKA, M. YANIV, M. VASSEUR and D. BLANGY. Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region. Cell, 1980, 20, 393-399.
\\ \\
10.	M. KATINKA, M. VASSEUR, N. MONTREAU, M. YANIV and D. BLANGY. Polyoma DNA sequences involved in control of viral gene expression in murine embryonal carcinoma cells. Nature, 1981, 290, 720-722.
\\ \\
11.	P. HERBOMEL, S. SARAGOSTI, D. BLANGY and M. YANIV. Fine structure of the origin-proximal DNase I-hypersensitive region in wild type and EC mutant polyoma. Cell, 1981, 25, 651-658.
\\ \\
12.	O.DANOS, M. KATINKA and M. YANIV. Human papillomavirus Ia complete DNA sequence : a novel type of genome organization among papovaviridae. EMBO J., 1982, 1, 231-236.
\\ \\
13.	G. MOYNE, F. HARPER, S. SARAGOSTI and M. YANIV. Absence of nucleosomes in a histone-containing nucleoprotein complex obtained by dissociation of purified simian virus 40 virions. Cell, 1982, 30, 123-130.
\\ \\
14.	P. HERBOMEL, B. BOURACHOT and M. YANIV. Two distinct enhancers with different cell specificities coexist in the regulatory region of polyoma. Cell, 1984, 39, 653-662.
\\ \\
15.	J. PIETTE, M.-H. KRYSZKE and M. YANIV. Specific interaction of cellular factors with the B enhancer of polyoma virus. EMBO J., 1985, 4, 2675-2695.
\\ \\
16.	J. PIETTE and M.YANIV. Two different factors bind to the ß-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J., 1987, 6, 1331-1337.
\\ \\
17.	M.H. KRYSZKE, J. PIETTE and M. YANIV. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature, 1987, 328, 254-256.
\\ \\
18.	S. CEREGHINI, M. RAYMONDJEAN, A. GARCIA-CARRANCA, P. HERBOMEL and M. YANIV. Factors involved in control of tissue specific expression of albumin gene. Cell, 1987, 50, 627-638.
\\ \\
19.	S. CEREGHINI, M. BLUMENFELD and M. YANIV. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells. Genes and Development, 1988, 2, 957-974.
\\ \\
20.	R.P. RYSECK, S.I. HIRAI, M. YANIV and R. BRAVO. Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature, 1988, 334, 535-537.
\\ \\
21.	S.-I. HIRAI and M. YANIV. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence. The New biologist, 1989, 1, 181-191
\\ \\
22.	F. THIERRY, N. DOSTATNI, F. ARNOS and M. YANIV. Cooperative activation of transcription by BPV-1 E2 can occur over a large distance. Mol. Cell. Biol., 1990, 10, 4431-4437.
\\ \\
23.	V. DOUCAS, G. SPYROU and M. YANIV. Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits estrogen receptor activity in human breast cancer derived cells. EMBO J., 1991, 10, 2237-2245.
\\ \\
24.	N. DOSTATNI, P. F. LAMBERT, R. SOUSA, J. HAM, P. M. HOWLEY and M. YANIV. The functional BPV-1 E2 transsactivation protein can act as a repressor by preventing formation of the initiation complex. Genes and Develop., 1991, 5, 1657-1671.
\\ \\
25.	C. MUCHARDT and M. YANIV. A human homologue of S. cerevisiae SNF2/SW12 and drosophila brm genes co-operates with nuclear hormone receptors in transcriptional activation. EMBO J., 1993, 12, 4279-4290.
\\ \\
26.	C. M. PFARR, F. MECHTA, G. SPYROU, D. LALLEMAND, S. CARILLO and M. YANIV. Jun-D is a negative regulator of fibroblast growth. Cell, 1994, 76, 747-760.
\\ \\
27.	M. PONTOGLIO, J. BARRA, M. HADCHOUEL, A. DOYEN, C. KRESS, J. POGGI BACH, C. BABINET and M. YANIV. Hepatocyte Nuclear Factor 1 (HNF1) inactivation results in hepatic dysfunction, phenylketonuria and renal Fanconi syndrome. Cell, 1996, 84, 575-585.
\\ \\
28.	E. BOSSY-WETZEL, L. BAKIRI and M. YANIV. C-Jun overexpression triggers rapid apoptosis in mouse fibroblasts. EMBO J., 1997, 16, 1695-1709.
\\ \\
29.	C. MUCHARDT, B. BOURACHOT, J.-C. REYES and M. YANIV. Ras transformation is associated with decreased expression of a member of the brm/SNF2 ATPase of the SNF/SWI complex. EMBO J., 1998, 17, 223-231.
\\ \\
30.	J.C. REYES, J. BARRA, C. MUCHARDT, A. CAMUS, C. BABINET and M. YANIV. Altered control of cellular proliferation in the absence of mammalian Brahma (SNF2a). EMBO J., 1998, 17, 6979-6991.
\\ \\
31.	L. BAKIRI, D. LALLEMAND, E. BOSSY-WETZEL and M. YANIV. Cell cycle dependent variations in c-Jun and JunB phosphorylation ; a role in the control of cyclin D1 expression. EMBO J., 2000, 19, 2056-2068.
\\ \\
32.	J.B. WEITZMAN, L. FIETTE, K. MATSUO and M. YANIV. JunD protects cells from p53-dependent senescence and apoptosis. Mol. Cell 2000, 6, 1109-1119.
\\ \\
33.	KLOCHENDLER-YEIVIN, L. FIETTE, J. BARRA, C. MUCHARDT, C. BABINET and M. YANIV. Essential role for SNF5/INI1, a subunit of the SWI/SNF complexes in embryonic development and tumour suppression. EMBO Reports, 2000, 1, 500-506.
\\ \\
34.	D. GERALD, E. BERRA, Y. M. FRAPART, D. CHAN, A.J. GIACCIA, D. MANSUY, J. POUYSSEGUR, M. YANIV and F. MECHTA-GRIGORIOU. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell, 2004, 118, 781-794.
\\ \\
35.	E. FISCHER, E. LEGUE, A. DOYEN, F. NATO, J.-F. NICOLAS, V. TORRES, M. YANIV and M. PONTOGLIO. Defective planar cell polarization in polycystic kidney disease. Nature Genetics, 2006, 38, 21-23.
\\ \\
36.	E. BATSCHE, M. YANIV and C. MUCHARDT. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nature Structural & Molecular Biology, 2006, 13, 22-29.
\\ \\
37.	KLOCHENDLER-YEIVIN, E. PICARSKY and M. YANIV. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex. Mol. Cell. Biol., 2006, 26, 2661-2674.
\\ \\
38.     M.YANIV. The 50th anniversary of the publication of the operon theory in the journal of molecular biology: past, present and future.  J Mol Biol. 2011, 409, 1-6.

39.     M. YANIV. Chromatin Remodeling: From Transcription to Cancer. Cancer Genetics, 2014, 207, 352-357.